Adams, M., Thorp, J., Jermy, B., Kwong, A., Kõiv, K, Grotzinger, A., Nivard, M., Marshall, S., Milaneschi, Y., Baune, B., Müller-Myhsok, B., Penninx, B., Boomsma, D., Levinson, D., Breen, G., Pistis, G., Grabe, H., Tiemeier, H., Berger, K., Rietschel, M., Magnusson, P., Uher, R., Hamilton, S., Lucae, S., Lehto, K., Li, Q., Byrne, E., Hickie, I., Martin, N., Medland, S., Wray, N., Tucker-Drob, E., Lewis, C., McIntosh, A., Derks, E. and Jones, Lisa ORCID: https://orcid.org/0000-0002-5122-8334 (2024) Genome-wide meta-analysis of ascertainment and symptom structures of major depression in case-enriched and community cohorts. Psychological Medicine, 54 (12). pp. 3459-3468. ISSN Print:0033-2917 Online: 1469-8978
Preview |
Text
jones2.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview |
Preview |
Text
Binder1.pdf - Supplemental Material Available under License Creative Commons Attribution. Download (2MB) | Preview |
Abstract
Background
Diagnostic criteria for major depressive disorder allow for heterogeneous symptom profiles but genetic analysis of major depressive symptoms has the potential to identify clinical and etiological subtypes. There are several challenges to integrating symptom data from genetically informative cohorts, such as sample size differences between clinical and community cohorts and various patterns of missing data.
Methods
We conducted genome-wide association studies of major depressive symptoms in three cohorts that were enriched for participants with a diagnosis of depression (Psychiatric Genomics Consortium, Australian Genetics of Depression Study, Generation Scotland) and three community cohorts who were not recruited on the basis of diagnosis (Avon Longitudinal Study of Parents and Children, Estonian Biobank, and UK Biobank). We fit a series of confirmatory factor models with factors that accounted for how symptom data was sampled and then compared alternative models with different symptom factors.
Results
The best fitting model had a distinct factor for Appetite/Weight symptoms and an additional measurement factor that accounted for the skip-structure in community cohorts (use of Depression and Anhedonia as gating symptoms).
Conclusion
The results show the importance of assessing the directionality of symptoms (such as hypersomnia versus insomnia) and of accounting for study and measurement design when meta-analyzing genetic association data.
Item Type: | Article |
---|---|
Additional Information: | Lisa Jones is part of the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium which contributed to this article. More information about this group can be found in the supplementary material for this article. |
Uncontrolled Discrete Keywords: | depressive symptoms, genome-wide association study, Genomic SEM, major depressive disorder, psychometrics |
Subjects: | R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry |
Divisions: | Three Counties Medical School |
Related URLs: | |
Copyright Info: | © The Author(s), 2024. Published by Cambridge University Press., This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/) |
Depositing User: | Katherine Gordon-Smith |
Date Deposited: | 28 Oct 2024 11:45 |
Last Modified: | 13 Nov 2024 14:17 |
URI: | https://eprints.worc.ac.uk/id/eprint/14343 |
Actions (login required)
View Item |